Login / Signup

Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein.

Xiaobo MaoHao GuDonghoon KimYasuyoshi KimuraNing WangEnquan XuRamhari KumbharXiaotian MingHaibo WangChan ChenShengnan ZhangChunyu JiaYuqing LiuHetao BianSenthilkumar S KaruppagounderFatih AkkentliQi ChenLonggang JiaHeehong HwangSu Hyun LeeXiyu KeMichael ChangAmanda LiJun YangCyrus RastegarManjari SriparnaPreston GeSaurav BrahmachariSangjune KimShu ZhangYasushi ShimodaMartina SaarHaiqing LiuSin Ho KweonMingyao YingCreg J WorkmanDario A A VignaliUlrike C MullerCong LiuHan Seok KoValina L DawsonTed M Dawson
Published in: Nature communications (2024)
Pathologic α-synuclein (α-syn) spreads from cell-to-cell, in part, through binding to the lymphocyte-activation gene 3 (Lag3). Here we report that amyloid β precursor-like protein 1 (Aplp1) interacts with Lag3 that facilitates the binding, internalization, transmission, and toxicity of pathologic α-syn. Deletion of both Aplp1 and Lag3 eliminates the loss of dopaminergic neurons and the accompanying behavioral deficits induced by α-syn preformed fibrils (PFF). Anti-Lag3 prevents the internalization of α-syn PFF by disrupting the interaction of Aplp1 and Lag3, and blocks the neurodegeneration induced by α-syn PFF in vivo. The identification of Aplp1 and the interplay with Lag3 for α-syn PFF induced pathology deepens our insight about molecular mechanisms of cell-to-cell transmission of pathologic α-syn and provides additional targets for therapeutic strategies aimed at preventing neurodegeneration in Parkinson's disease and related α-synucleinopathies.
Keyphrases
  • single cell
  • neoadjuvant chemotherapy
  • cell therapy
  • stem cells
  • gene expression
  • dna methylation
  • lymph node
  • radiation therapy
  • endothelial cells
  • high glucose
  • transcription factor
  • mouse model
  • genome wide identification